{"id":"https://openalex.org/W1976480751","doi":"https://doi.org/10.1177/0269881108089816","title":"Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial","display_name":"Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial","alternate_titles":[],"publication_year":2008,"publication_date":"2008-05-30","ids":{"openalex":"https://openalex.org/W1976480751","doi":"https://doi.org/10.1177/0269881108089816","mag":"1976480751","pmid":"https://pubmed.ncbi.nlm.nih.gov/18515465"},"language":"en","primary_location":{"id":"doi:10.1177/0269881108089816","doi":"https://doi.org/10.1177/0269881108089816","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881108089816","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1976480751"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089053830","display_name":"Hamid Afshar","orcid":"https://orcid.org/0000-0001-7787-8725","observed_orcids":["https://orcid.org/0000-0001-7787-8725"]},"institutions":[{"id":"https://openalex.org/I114982161","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56","country_code":"IR","type":"education","lineage":["https://openalex.org/I114982161"]}],"countries":["IR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Afshar","raw_affiliation_strings":["Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran","institution_ids":["https://openalex.org/I114982161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044946754","display_name":"Hamidreza Roohafza","orcid":"https://orcid.org/0000-0003-3582-0431","observed_orcids":["https://orcid.org/0000-0003-3582-0431"]},"institutions":[{"id":"https://openalex.org/I114982161","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56","country_code":"IR","type":"education","lineage":["https://openalex.org/I114982161"]}],"countries":["IR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"H Roohafza","raw_affiliation_strings":["Mental Health Department, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mental Health Department, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran","institution_ids":["https://openalex.org/I114982161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004440635","display_name":"Seyed Ghafur Mousavi","orcid":"https://orcid.org/0000-0001-8769-6001","observed_orcids":["https://orcid.org/0000-0001-8769-6001"]},"institutions":[{"id":"https://openalex.org/I114982161","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56","country_code":"IR","type":"education","lineage":["https://openalex.org/I114982161"]}],"countries":["IR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G Mousavi","raw_affiliation_strings":["Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran","institution_ids":["https://openalex.org/I114982161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054176523","display_name":"Sharareh Golchin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114982161","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56","country_code":"IR","type":"education","lineage":["https://openalex.org/I114982161"]}],"countries":["IR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Golchin","raw_affiliation_strings":["Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran","institution_ids":["https://openalex.org/I114982161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053859312","display_name":"Nafiseh Toghianifar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114982161","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56","country_code":"IR","type":"education","lineage":["https://openalex.org/I114982161"]}],"countries":["IR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N Toghianifar","raw_affiliation_strings":["Mental Health Department, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mental Health Department, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran","institution_ids":["https://openalex.org/I114982161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075190743","display_name":"Masoumeh Sadeghi","orcid":"https://orcid.org/0000-0001-7179-5558","observed_orcids":["https://orcid.org/0000-0001-7179-5558","https://orcid.org/0000-0003-4350-3591"]},"institutions":[{"id":"https://openalex.org/I114982161","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56","country_code":"IR","type":"education","lineage":["https://openalex.org/I114982161"]}],"countries":["IR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Sadeghi","raw_affiliation_strings":["Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences. Isfahan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences. Isfahan, Iran","institution_ids":["https://openalex.org/I114982161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019789555","display_name":"Mohammad Talaei","orcid":"https://orcid.org/0000-0002-6901-3665","observed_orcids":["https://orcid.org/0000-0002-6901-3665"]},"institutions":[{"id":"https://openalex.org/I114982161","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56","country_code":"IR","type":"education","lineage":["https://openalex.org/I114982161"]}],"countries":["IR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Talaei","raw_affiliation_strings":["COX Research Group, Consultation Department, Isfahan University of Medical Sciences, Isfahan, Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"COX Research Group, Consultation Department, Isfahan University of Medical Sciences, Isfahan, Iran","institution_ids":["https://openalex.org/I114982161"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5044946754"],"corresponding_institution_ids":["https://openalex.org/I114982161"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":4.2677,"has_fulltext":false,"cited_by_count":96,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93460675,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"23","issue":"2","first_page":"157","last_page":"162"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glutamate-receptor-antagonists","display_name":"glutamate receptor antagonists","score":0.8199999928474426},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.8109999895095825},{"id":"https://openalex.org/keywords/antipsychotic-induced-weight-gain","display_name":"antipsychotic-induced weight gain","score":0.8690000176429749},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.8199999928474426},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.8853245973587036},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.8033633828163147},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7752331495285034},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.708005964756012},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5601920485496521},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.527458906173706},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5081102848052979},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5002431869506836},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.426904559135437},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41603001952171326},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.40513312816619873},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.27481451630592346},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.08735990524291992},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881108089816","doi":"https://doi.org/10.1177/0269881108089816","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881108089816","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:18515465","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18515465","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322245","display_name":"Isfahan University of Medical Sciences","ror":"https://ror.org/04waqzz56"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W605991451","https://openalex.org/W1531379989","https://openalex.org/W1982321740","https://openalex.org/W1987047506","https://openalex.org/W1988714288","https://openalex.org/W1996015681","https://openalex.org/W2001214950","https://openalex.org/W2005266186","https://openalex.org/W2013032568","https://openalex.org/W2028884770","https://openalex.org/W2041045231","https://openalex.org/W2041854051","https://openalex.org/W2043555654","https://openalex.org/W2082897031","https://openalex.org/W2093539065","https://openalex.org/W2096964020","https://openalex.org/W2105930062","https://openalex.org/W2114024409","https://openalex.org/W2126680030","https://openalex.org/W2140606211","https://openalex.org/W2158137297","https://openalex.org/W2170034991","https://openalex.org/W2174437107","https://openalex.org/W2320918233","https://openalex.org/W4295332804"],"related_works":["https://openalex.org/W2298324108","https://openalex.org/W2992367707","https://openalex.org/W2005266186","https://openalex.org/W2515404667","https://openalex.org/W2183820020","https://openalex.org/W2565276737","https://openalex.org/W2466123555","https://openalex.org/W2596357186","https://openalex.org/W1996015681","https://openalex.org/W4394178750"],"abstract_inverted_index":{"Glutamate":[0],"antagonists":[1],"such":[2],"as":[3,24],"topiramate":[4,75,121,154],"have":[5],"been":[6],"proposed":[7],"based":[8],"on":[9,40,98,212],"the":[10,28,120,142,162],"glutamate":[11],"hypothesis":[12],"of":[13,30,80,94],"schizophrenia":[14],"because":[15],"its":[16,19,210],"properties":[17],"encourage":[18],"exploration":[20],"and":[21,63,87,92,104,116,128,138,177,215],"possible":[22],"development":[23],"a":[25,74],"medication":[26,61,81,204],"for":[27,148],"treatment":[29,95],"schizophrenia.":[31,46],"A":[32],"randomised,":[33],"double-blind,":[34],"placebo-controlled":[35],"clinical":[36],"trial":[37],"was":[38,82,96,188],"performed":[39],"18-":[41],"to":[42,73],"45-year-old":[43],"patients":[44],"with":[45,133,161],"Baseline":[47],"information":[48],"including":[49],"vital":[50],"signs,":[51],"height,":[52],"weight,":[53],"smoking":[54],"status,":[55],"demographic":[56],"characteristics,":[57],"(past)":[58],"psychiatric":[59],"history,":[60],"history":[62],"medication-related":[64],"adverse":[65],"effects":[66],"were":[67,70,123,169],"collected.":[68],"Patients":[69],"randomly":[71],"assigned":[72],"or":[76],"placebo":[77,143,163],"group.":[78,144,164],"Efficacy":[79],"measured":[83],"by":[84],"administering":[85],"Positive":[86],"Negative":[88],"Syndrome":[89],"Scale":[90],"(PANSS),":[91],"tolerability":[93],"recorded":[97],"day":[99,102,105,114,117],"0":[100],"(baseline),":[101],"28":[103,115],"56.":[106],"PANSS":[107,157],"values":[108,158],"(95%":[109],"confidence":[110],"interval)":[111],"at":[112],"baseline,":[113],"56":[118],"in":[119,141,171,186,191,205],"group":[122],"96.87":[124],"(85.37-108.37),":[125],"85.68":[126],"(74.67-96.70)":[127],"76.87":[129],"(66.06-87.69),":[130],"respectively;":[131],"compared":[132,160],"101.87":[134],"(90.37-113.37),":[135],"100.31":[136],"(89.29-111.32)":[137],"100.56":[139],"(89.74-111.37)":[140],"General":[145],"linear":[146],"model":[147],"repeated":[149],"measures":[150],"analysis":[151],"showed":[152],"that":[153],"has":[155],"lowered":[156],"significantly":[159,189],"Similar":[165],"significant":[166],"decline":[167],"patterns":[168],"found":[170],"all":[172],"three":[173],"subscales":[174],"(negative,":[175],"positive":[176],"psychopathology":[178],"sign).":[179],"Clinical":[180],"response":[181],"(more":[182],"than":[183,194],"20%":[184],"reduction":[185],"PANSS)":[187],"higher":[190],"topiramate-treated":[192],"subjects":[193],"controls":[195],"(50%":[196],"vs":[197],"12.5%).":[198],"Topiramate":[199],"can":[200],"be":[201],"an":[202],"effective":[203],"controlling":[206,216],"schizophrenic":[207],"symptoms,":[208],"considering":[209],"effect":[211],"negative":[213],"symptoms":[214],"antipsychotic-associated":[217],"weight":[218],"gain.":[219]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1976480751","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
